Perrigo (NYSE:PRGO – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 2.290-3.100 for the period, compared to the consensus estimate of 2.990. The company issued revenue guidance of $4.4 billion-$4.5 billion, compared to the consensus revenue estimate of $4.4 billion.
Wall Street Analyst Weigh In
Several research analysts have recently commented on PRGO shares. Argus lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. StockNews.com downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Wednesday, February 19th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $33.00.
View Our Latest Research Report on PRGO
Perrigo Price Performance
Perrigo (NYSE:PRGO – Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.53 by $0.07. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. Equities analysts forecast that Perrigo will post 2.56 EPS for the current fiscal year.
Perrigo Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Friday, May 30th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 4.71%. The ex-dividend date is Friday, May 30th. Perrigo’s payout ratio is -92.80%.
Insider Buying and Selling
In related news, EVP Ronald Craig Janish sold 7,800 shares of the firm’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $27.44, for a total transaction of $214,032.00. Following the transaction, the executive vice president now owns 33,666 shares in the company, valued at $923,795.04. This trade represents a 18.81 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.70% of the stock is owned by company insiders.
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Further Reading
- Five stocks we like better than Perrigo
- 3 Healthcare Dividend Stocks to Buy
- These 3 Rock Star Entertainment Stocks Are Dominating 2025
- Using the MarketBeat Dividend Yield Calculator
- Archer Stock Eyes Q1 Earnings After UAE Updates
- Find and Profitably Trade Stocks at 52-Week Lows
- Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx Boost
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.